Graphic version of this page | Change how these pages look
Home←Clinical support←Formulary←Brimonidine gel (Mirvaso®)
Brimonidine gel (Mirvaso®)
- Traffic Light
Grey
- BNF
13.6.3
- Licensed Indicators
Symptomatic treatment of facial erythema of rosacea patients
- Reference
APC May 14
- Criteria
- Provisional
Yes
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik